Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pemigatinib in the Advanced Gastrointestinal Cancer With FGFR 1-3 Alterations	Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, neoplasm	Recruiting	Phase 2	2022-12-15		NCT05651672

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Tianjin Medical University Cancer Institute and Hospital	287

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tianjin Medical University Cancer Institute & Hospital	Tianjin	China	58

Clinical trials